- Home
- EWTX vs CECO Comparison
EWTX vs CECO Comparison
Compare EWTX & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- CECO
- Stock Information
- Founded
- EWTX 2017
- CECO 1966
- Country
- EWTX United States
- CECO United States
- Employees
- EWTX N/A
- CECO N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- CECO Pollution Control Equipment
- Sector
- EWTX Health Care
- CECO Industrials
- Exchange
- EWTX Nasdaq
- CECO Nasdaq
- Market Cap
- EWTX 1.6B
- CECO 1.7B
- IPO Year
- EWTX 2021
- CECO N/A
- Fundamental
- Price
- EWTX $21.22
- CECO $52.11
- Analyst Decision
- EWTX Buy
- CECO Strong Buy
- Analyst Count
- EWTX 10
- CECO 4
- Target Price
- EWTX $36.90
- CECO $47.50
- AVG Volume (30 Days)
- EWTX 1.0M
- CECO 546.1K
- Earning Date
- EWTX 11-06-2025
- CECO 10-28-2025
- Dividend Yield
- EWTX N/A
- CECO N/A
- EPS Growth
- EWTX N/A
- CECO 334.15
- EPS
- EWTX N/A
- CECO 1.43
- Revenue
- EWTX N/A
- CECO $718,253,000.00
- Revenue This Year
- EWTX N/A
- CECO $39.21
- Revenue Next Year
- EWTX N/A
- CECO $13.44
- P/E Ratio
- EWTX N/A
- CECO $36.51
- Revenue Growth
- EWTX N/A
- CECO 29.86
- 52 Week Low
- EWTX $10.60
- CECO $17.57
- 52 Week High
- EWTX $35.99
- CECO $56.19
- Technical
- Relative Strength Index (RSI)
- EWTX 74.48
- CECO 51.19
- Support Level
- EWTX $16.70
- CECO $51.20
- Resistance Level
- EWTX $18.26
- CECO $55.26
- Average True Range (ATR)
- EWTX 1.25
- CECO 3.03
- MACD
- EWTX 0.39
- CECO 0.14
- Stochastic Oscillator
- EWTX 93.28
- CECO 67.17
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About CECO CECO Environmental Corp.
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.